Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling
Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling
复制标题
β-arrestin 1 的下调通过抑制 Src 信号传导抑制胶质母细胞瘤细胞的恶性进展
DOI:
10.1016/j.yexcr.2017.04.023
复制
发表时间:
2017-08-01
影响因子:
3.7
通讯作者:
Yu, Chunjiang
中科院分区:
文献类型:
--
作者:
Lan, Tian;Wang, Haoran;Yu, Chunjiang
Glioblastoma multiforme (GBM) is one of the most common brain malignancies worldwide and is typically associated with a dismal prognosis, yet the mechanisms underlying its aggressiveness remain unclear. Here, we revealed that beta-arrestin 1 was overexpressed in GBM and contributed to poorer outcome. Knockdown of beta-arrestin 1 suppressed the proliferation, invasiveness and glycolysis of GBM cells, and also enhanced temozolomide efficacy. Further, we discovered that knockdown of beta-arrestin 1 decreased the activity of Src, and suppression of Src signaling was critically involved in beta-arrestin 1 silencing-mediated suppression of GBM malignancies. Finally, we investigated the effect of beta-arrestin 1 knockdown on the tumor growth and survival of xenograft models, and found that sh beta-arrestin 1 apparently inhibited GBM growth in vivo and resulted in better survival of mice. Taken together, our findings suggest that knockdown of beta-arrestin 1 can suppress GBM cell proliferation, invasion and glycolysis by inhibiting Src signaling. Thus, targeting beta-arrestin 1 may be a potential therapeutic strategy for GBM treatment.